Deep Track Capital, LP 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 09:46 am Sale |
2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 531,857 0.700% |
-6,990,424 (-92.93%) |
Filing |
| 2024-02-14 08:58 am Purchase |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 7,522,281 9.990% |
2,940,281 (+64.17%) |
Filing |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 4,582,000 7.140% |
1,146,800 (+33.38%) |
Filing |
| 2022-05-16 4:55 pm Purchase |
2022-05-06 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 3,435,200 5.410% |
985,200 (+40.21%) |
Filing |
| 2022-02-14 09:01 am Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 2,450,000 4.000% |
-640,200 (-20.72%) |
Filing |
| 2021-08-13 4:27 pm Purchase |
2021-08-04 | 13G | Travere Therapeutics, Inc. TVTX |
Deep Track Capital, LP | 3,090,200 5.090% |
3,090,200 (New Position) |
Filing |